Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Syndax Pharmaceuticals (SNDX) Other Operating Expenses (2019)

Syndax Pharmaceuticals (SNDX) has disclosed Other Operating Expenses for 1 consecutive years, with $8.3 million as the latest value for Q2 2019.

  • For Q2 2019, Other Operating Expenses changed N/A year-over-year to $8.3 million; the TTM value through Mar 2020 reached $8.3 million, changed N/A, while the annual FY2025 figure was $1.3 million, 419.43% up from the prior year.
  • Other Operating Expenses hit $8.3 million in Q2 2019 for Syndax Pharmaceuticals.
  • Across five years, Other Operating Expenses topped out at $8.3 million in Q2 2019 and bottomed at $8.3 million in Q2 2019.